SFXN4 and ovarian carcinoma: As shown in Fig. 5A,B, in both COV362 HGSOC cells and in FTT ovarian cancer stem cells, SFXN4 knockdown significantly increased DNA damage following cisplatin treatment, consistent with the ability of SFXN4 knockdown to attenuate DNA repair.